N@N

Emergent BioSolutions to Participate in June 2010 Investor Conferences

^{Published on 2010-06-01 19:20:48 - Market Wire}
 

ROCKVILLE, Md.--([ BUSINESS WIRE ])--Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be participating in the following investor conferences during June 2010.

• The Jefferies & Company 2010 Global Life Sciences Conference
  New York, NY.
  June 8, 2010
  Corporate Overview Presentation
  11:00 AM Eastern
  There will be a full webcast with slides that will include discussion of the Companya™s business activities, financial outlook and current news.

• The Needham & Company 9^th Annual Healthcare Conference
  New York, NY.
  June 10, 2010
  Corporate Overview Presentation
  3:20 PM Eastern
  There will be a full webcast with slides that will include discussion of the Companya™s business activities, financial outlook and current news.

Both webcasts will be accessible from the Emergent website [ www.emergentbiosolutions.com ] under aInvestorsa.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodya™s immune system to prevent or treat disease. Emergenta™s marketed product, BioThrax^® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergenta™s product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia. Additional information may be found at [ www.emergentbiosolutions.com ].